Full text is available at the source.
The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
How Diet-Related Harmful Compounds and Genetic Risk May Influence the Development of Inflammatory Bowel Disease
AI simplified
Abstract
During a median follow-up of 13.72 years, 671 participants developed inflammatory bowel disease (IBD).
- Dietary intake of Nε-(1-carboxyethyl)-lysine (CEL) is associated with an increased risk of IBD (HR = 1.09).
- CEL intake is also linked to a heightened risk of Crohn's disease (CD) (HR = 1.18).
- The increased risk of IBD associated with CEL is particularly notable among participants who are overweight, physically inactive, and non-smokers.
- Among individuals at high genetic risk for CD, higher risks were observed for other dietary AGEs, including CML and MG-H1.
- No significant association was found between dietary AGEs and ulcerative colitis (UC) risk, regardless of genetic predisposition.
AI simplified